Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial.
Kishal Lukhna, Derek J Hausenloy, Abdelbagi Sidahmed Ali...
https://pubmed.ncbi.nlm.nih.gov/34739648/Actively Recruiting
Led by University of Cape Town · Updated on 2025-04-03
1400
Participants Needed
20
Research Sites
N/A
Total Duration
The RIC-AFRICA trial is a multi-center, sham-controlled, randomized controlled trial involving 1400 patients who have experienced ST-segment elevation myocardial infarction STEMI within 24 hours of symptom onset. The study aims to find out if Remote Ischaemic Conditioning RIC can reduce death rates and early heart failure after a heart attack in patients mainly treated with clot-busting therapy. It also includes an observational group of patients presenting between 24 and 72 hours after the heart attack to study similar outcomes without treatment intervention. Participants are randomly assigned to either the RIC group or a sham control group. Those in the RIC group will receive four cycles of blood pressure cuff inflation to 20 mmHg above their systolic blood pressure for 5 minutes, followed by 5 minutes of deflation, repeated four times, and this protocol will be repeated daily for two more days. The sham group will undergo the same cycle with low-pressure inflation to 20 mmHg. The observational group, who present later, will not receive intervention but will be followed with the same outcome measures. Throughout the study, participants will be monitored for all-cause death and new onset heart failure within 30 days after the heart attack. Assessments will include clinical evaluations, ECG, biomarkers, and echocardiography to confirm STEMI and heart function. The study will also track major adverse cardiac and cerebrovascular events at 30 days. The total participation duration varies based on the group, with interventions over three days for the randomized groups and observation for up to 72 hours for the non-randomized group.
CONDITIONS
Remote Ischaemic Conditioning in STEMI Patients in AFRICA
K
Kishal Lukhna, MBChB
S
Sara Giesz
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Cape Town
Lead Sponsor
Groote Schuur Hospital, South Africa
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 days
Participants presenting within 24 hours of MI onset are randomised to receive either Remote Ischaemic Conditioning (RIC) or a sham control using a pneumatic cuff applied to the upper arm prior to thrombolysis. The intervention involves cycles of cuff inflation and deflation repeated daily for 3 days.
Daily treatment sessions for 3 consecutive days
Duration - Up to 48 hours after screening
Participants presenting between 24 and 72 hours after MI onset who are ineligible for the intervention are observed without receiving the RIC or sham treatments, with the same study endpoints assessed.
Observational monitoring with no intervention visits
Duration - 30 days
Participants are followed for up to 30 days post-MI to assess clinical outcomes including death and heart failure.
Follow-up visits to assess health status up to 30 days post-MI
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Kishal Lukhna, Derek J Hausenloy, Abdelbagi Sidahmed Ali...
https://pubmed.ncbi.nlm.nih.gov/34739648/University of Cape Town
Lead Sponsor
Groote Schuur Hospital, South Africa
Collaborating Sponsor